Wendell David Associates Inc Bristol Myers Squibb CO Transaction History

Wendell David Associates Inc

$1.05 Billion
Q3 2024

A detailed history of Wendell David Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wendell David Associates Inc holds 19,209 shares of BMY stock, worth $1.13 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

19,209

Previous 19,724 2.61%

Holding current value

$1.13 Million

Previous $819,000 21.37%

% of portfolio

0.1%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $20,424 - $26,651	-515 Reduced 2.61%	19,209 $994,000
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $10,939 - $12,403	-228 Reduced 1.14%	19,724 $1.07 Million
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $41,353 - $49,346	853 Added 4.47%	19,952 $1.02 Million
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $46,312 - $51,784	800 Added 4.37%	19,099 $1.11 Million
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $49,218 - $53,598	-795 Reduced 4.16%	18,299 $1.22 Million
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $20,116 - $22,624	-339 Reduced 1.74%	19,094 $1.21 Million
Q4 2020 Jan 22, 2021	BUY	$57.74 - $65.43 $9,931 - $11,253	172 Added 0.89%	19,433 $1.21 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $2,871 - $3,182	-50 Reduced 0.26%	19,261 $1.16 Million
Q2 2020 Jul 17, 2020	SELL	$54.82 - $64.09 $8,223 - $9,613	-150 Reduced 0.77%	19,311 $1.14 Million
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $34,800 - $50,572	-750 Reduced 3.71%	19,461 $1.09 Million
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $284,187 - $370,697	5,775 Added 40.0%	20,211 $1.3 Million
Q3 2019 Oct 22, 2019	SELL	$42.77 - $50.71 $4,277 - $5,071	-100 Reduced 0.69%	14,436 $732,000
Q2 2019 Jul 16, 2019	SELL	$44.62 - $49.34 $22,310 - $24,670	-500 Reduced 3.33%	14,536 $659,000
Q1 2019 Apr 11, 2019	SELL	$45.12 - $53.8 $9,024 - $10,760	-200 Reduced 1.31%	15,036 $717,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $85,281 - $110,589	-1,749 Reduced 10.3%	15,236 $792,000
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $32,895 - $40,999	-651 Reduced 3.69%	16,985 $940,000
Q1 2018 Apr 11, 2018	SELL	$59.92 - $68.98 $5,992 - $6,898	-100 Reduced 0.56%	17,636 $1.12 Million
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $92,907 - $101,292	1,550 Added 9.58%	17,736 $1.09 Million
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $893,952 - $1.03 Million	16,186	16,186 $1.03 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Bristol Myers Squibb CO Transaction History